Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
- DOI
- 10.1038/s41380-018-0256-5
- Published
- 2020 Jul
- Container
- Molecular psychiatry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41380-018-0256-5,
title = {Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).},
author = {Fava M and Freeman MP and Flynn M and Judge H and Hoeppner BB and Cusin C and Ionescu DF and Mathew SJ and Chang LC and Iosifescu DV and Murrough J and Debattista C and Schatzberg AF and Trivedi MH and Jha MK and Sanacora G and Wilkinson ST and Papakostas GI},
year = {2020},
journal = {Molecular psychiatry},
doi = {10.1038/s41380-018-0256-5},
url = {https://doi.org/10.1038/s41380-018-0256-5}
}RIS
TY - JOUR TI - Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). AU - Fava M AU - Freeman MP AU - Flynn M AU - Judge H AU - Hoeppner BB AU - Cusin C AU - Ionescu DF AU - Mathew SJ AU - Chang LC AU - Iosifescu DV AU - Murrough J AU - Debattista C AU - Schatzberg AF AU - Trivedi MH AU - Jha MK AU - Sanacora G AU - Wilkinson ST AU - Papakostas GI PY - 2020 JO - Molecular psychiatry DO - 10.1038/s41380-018-0256-5 UR - https://doi.org/10.1038/s41380-018-0256-5 ER -
APA
M, F., MP, F., M, F., H, J., BB, H., C, C., DF, I., SJ, M., LC, C., DV, I., J, M., C, D., AF, S., MH, T., MK, J., G, S., ST, W., & GI, P. (2020). Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).. Molecular psychiatry. https://doi.org/10.1038/s41380-018-0256-5
Source records
- pubmed · retrieved 2026-09-26T18:21:25.450Z